Snehal Patel insider trades

Open-market stock purchases and sales by Snehal Patel, CEO and CFO at Greenwich LifeSciences, Inc, from SEC Form 4 filings since Sep 29, 2020.

Track record: 94% of 78 scored buys are up 5% or more since purchase, averaging +92%.

Recent trades

DateStockTradeValue
Jan 13, 2026GLSI Greenwich LifeSciences, IncBought$53.7K
Jan 12, 2026GLSI Greenwich LifeSciences, IncBought$79.9K
Dec 31, 2025GLSI Greenwich LifeSciences, IncBought$91.8K
Dec 30, 2025GLSI Greenwich LifeSciences, IncBought$63K
Dec 18, 2025GLSI Greenwich LifeSciences, IncBought$51.7K
Nov 25, 2025GLSI Greenwich LifeSciences, IncBought$38.5K
Nov 13, 2025GLSI Greenwich LifeSciences, IncBought (not open market)—
Nov 7, 2025GLSI Greenwich LifeSciences, IncBought$89.4K
Oct 31, 2025GLSI Greenwich LifeSciences, IncBought$21.3K

Companies traded

  • GLSI Greenwich LifeSciences, Inc: 82 buys, last Jan 13, 2026

Get free alerts when Snehal Patel files a new trade →